|Company||Collaborations in Chemistry and Molecular Materials Informatics, Inc.|
|Key people||Sean Ekins, Dr. Alex M. Clark|
Open Drug Discovery Teams ODDT is an open science content aggregator for topics such as rare/neglected diseases and precompetitive research. It is being designed and developed by Sean Ekins of Collaborations in Chemistry and Alex M. Clark of Molecular Materials Informatics. The app is currently in the beta phase it has been made available to the public as a freely downloadable app for all iOS devices ODDT for iPhone, iPod and iPad .
Other mentions on blogs: pistoia alliance blog
ODDT was developed as part of a challenge organized by the Pistoia Alliance. They wanted to run an ice breaker one evening during their 2012 face to face board meeting in London at which a number of groups could come up with a service for pharma for 2014. Sean decided that if he was going to do it he may as well do something that he was passionate about. One evening he sketched out the slides in a brainstorming session:
He forwarded them to a couple of trusted friends. One of them, Alex wanted to develop the idea shown in the final slide. Alex developed a prototype app in time to demo live at the meeting. The inspiration for the idea of ODDT came from Science online session that inspired itanother science online session that inspired it the rare disease organisation that inspired it we are grateful for the use of the image from Jonas Just Begun.
To date we have developed this app without funding and made it freely available. We would be happy for disease foundations, societies, individuals and companies to fund or sponsor research topics. We hope that scientists will increasingly tweet links to papers, blogs, slides and molecules of relevance to scientists following the topic hashtags.
We welcome suggestions for other diseases and topics to follow.
 App vision
The ODDT project uses a free mobile app as user entry point. The app has a magazine-like interface, and server-side infrastructure for hosting chemistry-related data as well as value added services. The project is open to participation from anyone and provides the ability for users to make annotations and assertions, thereby contributing to the collective value of the data to the engaged community. Much of the content is derived from public sources, but the platform is also amenable to commercial data input. The technology could also be readily used in-house by organizations as a research aggregator that could integrate internal and external science and discussion. The infrastructure for the app is currently based upon the Twitter API as a useful proof of concept for a real time source of publicly generated content. This could be extended further by accessing other APIs providing news and data feeds of relevance to a particular area of interest. As the project evolves, social networking features will be developed for organizing participants into teams, with various forms of communication and content management possible.
 Technical Details
The entry screen to the app displays the topics ranked by use.
On the entry screen, tapping the statistics summary button opens a listing of endorsements, disapprovals, injections and retirements for each hashtag.
Tapping a topic image opens the topic browser, starting with the incoming page. Newly added content is listed on the right. Each tweet that has been introduced into the data collection is referred to a factoid. A factoid can be endorsed or disapproved, and the hyperlinks can be followed.
The recent page shows factoids with one or more vote.
The content section shows the most popular voted content in rank order.
Molecule thumbnails can be tapped to open in other apps like MolSync or SAR Table, for example.
 Papers, Posters and Presentations
We have just posted a video to you tube that describes ODDT ODDT video
Alex Pitching ODDT in Montreal to VCs Pitch to VCs
Slides, pitch for app and alpha version flier documenting the progress of the idea:
Early versions of the app have also been shown at the following meetings:
- mention at triconference
- at rare disease conference
- mobile apps talk at ACS
- collaboration talk at ACS
- talk on wikis to databases at ACS
If you would like to sponsor development of this app please see our pitch pitch for sponsorship
 Licensing & Availability
The app is currently in beta testing. It is available for free on the iTunes AppStore. While the app can be used to browse the topics anonymously, participation requires enabling access to a Twitter account.